New analysis shows significant long-term potential in Brighter’s various offers and the company’s share price
Brighter AB [publ], today announced that Aktiespararna has provided an updated company analysis. Included in Aktiespararna’s update is an analysis of the key milestones that Brighter has completed across the company’s three product lines: Actiste®, Camanio and Nectarine Health. Brighter signed distribution agreements in three new markets: Ghana, Nigeria and Qatar for Actiste and received market approvals for Actiste® and Actiste® Mini in various regions. The analysis continues to discuss the establishment of a framework agreement with Sweden's Municipalities and Regions for Camanio